*Refresh the page if the below document does not appear.
Now comes word that more leaders may be on their way out. Up to half of the 1,400 jobs that the pharmaceutical giant intends to eliminate in Switzerland will be in positions of leadership.
The anticonvulsant medication Carbamazepine Tablets, with a 200 mg strength, have been approved for sale in the US market, according to drug company Unichem Laboratories.
Indonesia National Agency for Drug and Food Control has given its approval to Takeda’s QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003 dengue vaccine).
According to CRISIL, new product launches and a 6–8% average price increase permitted by the National Pharmaceutical Pricing Authority in March 2022 are expected to drive the domestic formulations market’s 7-9% growth this fiscal year, up from 15% growth last year.
USFDA has given Merck’s investigational anticoagulant therapy MK-2060 Fast Track designation in order to lower the risk of major thrombotic cardiovascular events in patients with end-stage renal disease (ESRD).
As the Swiss eye-care company looks to expand its pipeline of optical treatments, Alcon AG announced that it would buy Aerie Pharmaceuticals in a deal estimated to be worth $753 million.
Pfizer Inc. and BioNTech SE announced that
they have completed a submission to the USFDA
requesting an Emergency Use Authorization for
a booster dose of an Omicron BA.4/BA.5
adapted bivalent Covid-19 vaccine for people
aged 12 and older.